All Title Author
Keywords Abstract


Evaluation of Mallotus oppositifolius Methanol Leaf Extract on the Glycaemia and Lipid Peroxidation in Alloxan-Induced Diabetic Rats: A Preliminary Study

DOI: 10.1155/2013/527205

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective. Mallotus oppositifolius (Geiseler) Müll. Arg. (Euphorbiaceae) is folklorically used to “treat” diabetic conditions in some parts of Nigeria therefore the study, to investigate the extract of the leaves for activities on hyperglycaemia, lipid peroxidation, and increased cholesterol levels in vivo in alloxan diabetic rats as well as its potential antioxidant activity in vitro. Methods. Albino rats (240–280?g) were given an injection of 120?mg/kg body weight, i.p. of alloxan monohydrate. After 8 days, diabetic animals with elevated fasting blood glucose levels (>9?mmol/L) were considered and selected for the study. Results. Oral treatment with the extract administered every 12?h by gavage at doses of 100, 200, and 400?mg/kg of the extract to the test rats, for 14 days, resulted in a significant dose-dependent decrease in blood glucose levels from 12.82 ± 1.02?mmol/dL to 4.92 ± 2.01?mmol/dL at the highest dose of 400?mg/kg compared to the control drug and glibenclamide as well as attendant significant decline in diabetic rats employed in the study. Conclusion. The extract also showed in vitro concentration-dependent antioxidant activity following the 1,1-diphenyl-2-picryl-hydrazyl (DPPH) and ferric reducing assays. Findings further suggest the presence of active antidiabetic and antioxidant principles in M. oppositifolius leaves. 1. Introduction Diabetes mellitus (DM) is a multifactorial syndrome resulting from a variable interaction of hereditary and environmental factors. It is characterized by inapt hyperglycaemia caused by damaged β-cells of the pancreas or resistance to the action of insulin at the cellular level, or possibly a combination of both factors [1, 2]. DM affects more than 200 million people worldwide and is projected to be one of the world’s major killers in the next 25 years [3], Nigeria with about 160 million people has the highest number of people with diabetes (approximately 1,338 × 103), thus, the highest diabetes prevalence in the African Region (19.1%), as well as the highest number of people with impaired glucose tolerance with an estimate of about 3.85 million people. With on-going researches in diabetes and oral hypoglycaemic agents (OHA), the management of DM is still a global problem. One important area in diabetes management receiving particular attention today is that of herbal hypoglycaemic agents. Several factors such as dyslipidemia or hyperlipidemia which are involved in the microvascular and macrovascular complications as well as hyperglycemia are associated with the diabetes disease which is the major cause of

References

[1]  M. K. Vinuthan, G. Kumara, M. Narayanaswamya, and T. Veena, “Lipid lowering effect of aqueous leaves extract of Murraya koenigii (curry leaf) on alloxan-induced male diabetic rats,” Pharmacognosy Magazine, vol. 3, pp. 112–115, 2007.
[2]  I. I. Ezeigbo, “Antidiabetic potential of methanolic leaf extracts of Icacina trichantha in alloxan-induced diabetic mice,” International Journal of Diabetes in Developing Countries, vol. 30, no. 3, pp. 150–152, 2010.
[3]  R. V. Jayakumar, “Herbal medicines for type-2 diabetes,” International Journal of Diabetes in Developing Countries, vol. 30, no. 3, pp. 111–112, 2010.
[4]  M. R. Taskinen, “Lipoprotein lipase in diabetes,” Diabetes/Metabolism Reviews, vol. 3, no. 2, pp. 551–570, 1987.
[5]  A. Scoppola, F. R. Montecchi, G. Menzinger, and A. Lala, “Urinary mevalonate excretion rate in type 2 diabetes: role of metabolic control,” Atherosclerosis, vol. 156, no. 2, pp. 357–361, 2001.
[6]  K. Uchimura, A. Nagasaka, R. Hayashi et al., “Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus,” Journal of Diabetes and Its Complications, vol. 13, no. 5-6, pp. 264–270, 1999.
[7]  N. H. Ugochukwu, N. E. Babady, M. Cobourne, and S. R. Gasset, “The effect of Gongronema latifolium extracts on serum lipid profile and oxidative stress in hepatocytes of diabetic rats,” Journal of Biosciences, vol. 28, no. 1, pp. 1–5, 2003.
[8]  F. A. Kabran, A. Maciuk, T. A. Okpekon et al., “Phytochemical and biological analysis of M. oppositifolius (Euphorbiaceae),” Planta Medica, vol. 78, no. 11, p. 1381, 2012.
[9]  E. O. Farombi, O. O. Ogundipe, and J. O. Moody, “Antioxidant and anti-inflammatory activities of Mallotus oppositifolium in model systems,” African Journal of Medicine and Medical Sciences, vol. 30, no. 3, pp. 213–215, 2001.
[10]  M. M. Iwu, Handbook of African Medicinal Plants, CRC Press, Boca Raton, Fla, USA, 1993.
[11]  M. U. Anthony and A. O. Adebimpe, “Hypoglycemic potential of the young leave methanolic extract of Mangifera indica in alloxan induced diabetic rat,” Pakistan Journal of Nutrition, vol. 8, no. 3, pp. 239–241, 2009.
[12]  I. I. Ezeigbo, “The antidiabetic potentials of the methanolic seed extract of Buchhlozia coriacea,” Annals of Medical and Health Sciences Research, vol. 1, no. 2, pp. 159–163, 2011.
[13]  N. Malviya, S. Jain, and S. Malviya, “Antidiabetic potential of medicinal plants,” Acta Poloniae Pharmaceutica—Drug Research, vol. 67, no. 2, pp. 113–118, 2010.
[14]  F. W. Sunderman Jr., A. Marzouk, S. M. Hopfer, S. M. Hopfer, O. Zaharia, and M. C. Reid, “Increased lipid peroxidation in tissues of nickel chloride-treated rats,” Annals of Clinical and Laboratory Science, vol. 15, no. 3, pp. 229–236, 1985.
[15]  C. C. Allain, L. S. Poon, and C. S. G. Chan, “Enzymatic determination of total serum cholesterol,” Clinical Chemistry, vol. 20, no. 4, pp. 470–475, 1974.
[16]  F. F. Benzie and J. J. Strain, “Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration,” Methods in Enzymology, vol. 299, pp. 15–27, 1998.
[17]  L. L. Mensor, F. S. Menezes, G. G. Leit?o et al., “Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method,” Phytotherapy Research, vol. 15, no. 2, pp. 127–130, 2001.
[18]  G. H. Schmelzer, E. G. Achigan-Dako, and C. H. Bosch, Medicinal Plants of Tropical Africa, PROTA Foundation, Nairobi, Kenya, 2010.
[19]  S. P. Wolff, Z. Y. Jiang, and J. V. Hunt, “Protein glycation and oxidative stress in diabetes mellitus and ageing,” Free Radical Biology and Medicine, vol. 10, no. 5, pp. 339–352, 1991.
[20]  R. N. Okigbo, C. L. Anuagasi, and J. E. Amadi, “Advances in selected medicinal and aromatic plants indigenous to Africa,” Journal of Medicinal Plant Research, vol. 3, no. 2, pp. 86–95, 2009.
[21]  E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000.
[22]  D. E. Gutstein and V. Fuster, “Pathophysiology and clinical significance of atherosclerotic plaque rupture,” Cardiovascular Research, vol. 41, no. 2, pp. 323–333, 1999.
[23]  M. O. Sofidiya, O. A. Odukoya, O. B. Familoni, and S. I. Inya-Agha, “Free radical scavenging activity of some Nigerian medicinal plant extracts,” Pakistan Journal of Biological Sciences, vol. 9, no. 8, pp. 1438–1441, 2006.
[24]  P. Hodek, P. Trefil, and M. Stiborová, “Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450,” Chemico-Biological Interactions, vol. 139, no. 1, pp. 1–21, 2002.
[25]  M. B. Krawinkel and G. B. Keding, “Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia,” Nutrition Reviews, vol. 64, no. 7, pp. 331–337, 2006.
[26]  J. K. Grover, S. Yadav, and V. Vats, “Medicinal plants of India with anti-diabetic potential,” Journal of Ethnopharmacology, vol. 81, no. 1, pp. 81–100, 2002.
[27]  K. Azad, J. M. Parkin, S. Court, M. F. Laker, and K. G. M. M. Alberti, “Circulating lipids and glycaemic control in insulin dependent diabetic children,” Archives of Disease in Childhood, vol. 71, no. 2, pp. 108–113, 1994.
[28]  V. A. Diwadkar, J. W. Anderson, S. R. Bridges, M. S. Gowri, and P. R. Oelgten, “Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples,” Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 2, pp. 178–184, 1999.
[29]  B. Rodrigues and J. H. McNeil, “Cardiac function in spontaneously hypertensive diabetic rats,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 251, no. 3, part 2, pp. H571–H580, 1986.
[30]  J. J. Genest, J. R. McNamara, D. N. Salem, and E. J. Schaefer, “Prevalence of risk factors in men with premature coronary artery disease,” The American Journal of Cardiology, vol. 67, no. 15, pp. 1185–1189, 1991.
[31]  M. D. Sharma, J. A. Farmer, and A. Garber, “Type 2 diabetes and cardiovascular risk factors,” Current Medical Research and Opinion, vol. 27, supplement 3, pp. 1–5, 2011.
[32]  G. N. Levine, J. F. Keaney Jr., and J. A. Vita, “Cholesterol reduction in cardiovascular disease—clinical benefits and possible mechanisms,” The New England Journal of Medicine, vol. 332, no. 8, pp. 512–521, 1995.

Full-Text

comments powered by Disqus